This formulation consists of Phenobarbital 50 mg in rectal suppository form. A suppository is a solid dosage form that is inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts to release medication for local or systemic absorption.

Phenobarbital is a barbiturate that acts as a central nervous system depressant. It is primarily used as an anticonvulsant to manage various types of seizures, including generalized tonic-clonic seizures, partial seizures, and status epilepticus. By enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, Phenobarbital helps to stabilize neuronal activity and prevent seizure propagation.

The rectal suppository form provides an alternative route of administration for patients who are unable to take medications orally, such as those experiencing vomiting, unconsciousness, or swallowing difficulties. This route allows for rapid absorption through the rectal mucosa, leading to quicker onset of action compared to oral administration.

For prescribers, Phenobarbital 50 mg rectal suppositories offer a valuable option in both acute and maintenance settings for seizure control. They are particularly useful in pediatric patients or in situations where intravenous access is not feasible. Dosage should be individualized based on the patient's age, weight, and specific clinical needs. Monitoring serum Phenobarbital levels may be necessary to ensure therapeutic effectiveness while minimizing potential toxicity.

Patients and caregivers should be instructed on the proper administration technique of rectal suppositories to ensure optimal absorption. Common side effects may include drowsiness, dizziness, and sedation. It is important to avoid engaging in activities that require mental alertness, such as driving or operating heavy machinery, until the individual response to the medication is known. Long-term use may lead to dependence; therefore, it should be used under close medical supervision.

If you have any questions, reach out to us.

Phenobarbital is a barbiturate that is commonly used for its sedative and anticonvulsant properties. When formulated as a 50 mg rectal suppository, it is designed to be inserted into the rectum, where it dissolves or melts to release the medication for systemic absorption. This route of administration can be particularly useful for patients who are unable to take oral medications due to vomiting, difficulty swallowing, or other gastrointestinal issues. Phenobarbital is primarily used in the management of seizure disorders, including epilepsy, and may also be used for sedation in certain medical procedures.

When considering the use of phenobarbital rectal suppositories, it is important to be aware of potential drug interactions that could affect the efficacy and safety of the treatment. Phenobarbital is known to induce hepatic enzymes, particularly cytochrome P450 enzymes, which can lead to increased metabolism and decreased plasma concentrations of various drugs. This can potentially reduce the effectiveness of medications such as anticoagulants (e.g., warfarin), oral contraceptives, and certain antiretrovirals. Patients using these medications may require dose adjustments or alternative therapies to maintain therapeutic efficacy.

Conversely, certain drugs can affect the metabolism of phenobarbital, leading to altered plasma levels and increased risk of adverse effects. For instance, valproic acid can inhibit the metabolism of phenobarbital, potentially leading to increased sedation and toxicity. Similarly, other central nervous system depressants, such as benzodiazepines, opioids, and alcohol, can have additive sedative effects when used concurrently with phenobarbital, increasing the risk of respiratory depression and sedation. Patients should be advised to avoid or limit the use of these substances while using phenobarbital suppositories.

Additionally, phenobarbital can interact with other anticonvulsants, such as phenytoin and carbamazepine, which may require careful monitoring and dose adjustments to maintain seizure control and minimize side effects. It is also important to consider the potential for interactions with over-the-counter medications and herbal supplements, as these can also influence the metabolism and effects of phenobarbital.

Patients and prescribers should be vigilant for signs of drug interactions, such as changes in seizure frequency, unexpected sedation, or other unusual symptoms. Regular monitoring of drug levels and clinical response is recommended to ensure optimal therapeutic outcomes. If you have any questions or concerns about potential drug interactions with phenobarbital rectal suppositories, please reach out to us for further guidance and support.

Phenobarbital 50 mg rectal suppositories are a specialized formulation designed to deliver the active medication, phenobarbital, directly into the body through the rectal cavity. This solid dosage form is particularly beneficial for patients who may have difficulty swallowing oral medications or require rapid absorption of the drug. Upon insertion into the rectum, the suppository dissolves or melts at body temperature, allowing the phenobarbital to be absorbed through the rectal mucosa into the bloodstream. This route of administration can provide both local and systemic effects, depending on the condition being treated.

Phenobarbital is a barbiturate that acts as a central nervous system depressant. It is primarily used for its anticonvulsant properties, making it effective in the management of various seizure disorders. By enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, phenobarbital helps to stabilize neuronal activity and prevent the excessive electrical discharges that characterize seizures. This mechanism of action makes it a valuable option for patients with epilepsy or other seizure-related conditions.

The rectal administration of phenobarbital offers several advantages. It bypasses the gastrointestinal tract, which can be beneficial for patients experiencing nausea, vomiting, or gastrointestinal disturbances that may interfere with oral medication absorption. Additionally, the rectal route can provide a more rapid onset of action compared to oral administration, which is crucial in acute situations where immediate seizure control is necessary. This makes phenobarbital suppositories a practical choice for both chronic management and emergency intervention in seizure disorders.

For prescribers, it is important to consider the appropriate dosing and frequency of administration when prescribing phenobarbital rectal suppositories. Factors such as the patient's age, weight, renal and hepatic function, and the severity of the condition should be taken into account to optimize therapeutic outcomes while minimizing potential side effects. Patients should be instructed on the correct method of insertion to ensure proper absorption and efficacy of the medication.

Patients using phenobarbital rectal suppositories should be aware of potential side effects, which may include drowsiness, dizziness, and ataxia. It is crucial to monitor for signs of excessive sedation or respiratory depression, particularly in individuals with compromised respiratory function or when used in conjunction with other central nervous system depressants. Regular follow-up with healthcare providers is recommended to assess the effectiveness of the treatment and make any necessary adjustments.

If you have any questions or require further information about phenobarbital 50 mg rectal suppositories, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation.

Phenobarbital 50 mg rectal suppositories are primarily used for the management of seizure disorders, particularly in patients who may have difficulty swallowing oral medications or require rapid absorption. However, this formulation can also be considered for other uses beyond its primary indication. One potential use is in the management of acute anxiety episodes or agitation, especially in patients who are unable to take oral medications due to nausea, vomiting, or other gastrointestinal issues. The rectal route can provide a more rapid onset of action compared to oral administration, which can be beneficial in acute situations.

Additionally, phenobarbital suppositories may be used in palliative care settings to manage symptoms such as severe anxiety, agitation, or insomnia in terminally ill patients. The ability to administer medication rectally can be particularly advantageous when oral administration is not feasible due to decreased consciousness or difficulty swallowing. In some cases, phenobarbital may also be used as a sedative for preoperative or procedural sedation, providing an alternative route of administration when intravenous access is challenging or not preferred.

For prescribers considering the use of phenobarbital rectal suppositories for these alternative indications, it is important to assess the patient's overall health status, potential drug interactions, and the appropriateness of the rectal route for the specific clinical scenario. Patients and caregivers should be educated on the proper administration technique for rectal suppositories to ensure optimal absorption and therapeutic effect. As with any medication, monitoring for side effects such as drowsiness, dizziness, or respiratory depression is crucial, particularly in populations that may be more sensitive to the effects of barbiturates, such as the elderly or those with compromised liver function.

If you have any questions or need further information about the use of phenobarbital rectal suppositories, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation.